肝血管病的病理学特征及鉴别诊断要点

罗文萍; 马红; 赵新颜

doi:10.3969/j.issn.1001-5256.2018.11.005

肝血管病的病理学特征及鉴别诊断要点

DOI: 10.3969/j.issn.1001-5256.2018.11.005

首都医科大学附属北京友谊医院肝病研究中心国家消化系统疾病临床医学研究中心

基金项目:

国家自然科学基金资助项目(81670545)；

详细信息

中图分类号: R575
计量
- 文章访问数: 1989
- HTML全文浏览量: 45
- PDF下载量: 492
- 被引次数: 0
出版历程
- 出版日期: 2018-11-20

Pathological features of hepatic vascular diseases and key points in differential diagnosis

Research funding:

摘要

摘要: 肝血管病是累及肝脏循环系统的一组异质性疾病。尽管肝血管病的发病率普遍较低,但却是发生门静脉高压症的一个重要原因。该类患者的发病年龄通常较小,误诊、误治可明显降低患者的预期寿命。熟练掌握肝血管病的临床表现、影像学及病理形态学特点,对于明确诊断及制订合理的治疗策略至关重要。重点介绍了常见肝血管病的病理特点及鉴别诊断要点。
- 肝疾病 /
- 血管疾病 /
- 病理学 /
- 诊断,鉴别
Abstract: Hepatic vascular diseases are a group of heterogeneous diseases which affect blood circulation in the liver. Although hepatic vascular diseases have a low incidence rate, they remain an important cause of portal hypertension. Patients often develop these diseases at a younger age, and misdiagnosis and/or mistreatment may greatly reduce their life expectancy. A good understanding of clinical manifestations, imaging features, and pathological features of hepatic vascular diseases is of vital importance in clarifying diagnosis and developing reasonable treatment strategies. This article introduces the pathological features of common hepatic vascular diseases and key points in differential diagnosis.
- liver diseases /
- vascular diseases /
- pathology /
- diagnosis, differential

HTML全文

参考文献(27)

[1] European Association for the Study of the Liver. EASL Clinical practice guidelines:Vascular diseases of the liver[J]. J Hepatol, 2016, 64 (1) :179-202.

[2] BURT AD, FERRELL LD, HUBSCHER SG. Mac Sween's pathology of the liver, seventh edition[M]. Philadelphia:Elsevier, Ltd, 2018:653-689.

[3] SARIN SK, KHANNA R. Non-cirrhotic portal hypertension[J]. Clin Liver Dis, 2014, 18 (2) :451-476.

[4] ROSKAMS T, BAPTISTA A, BIANCHI L, et al. Histopathology of portal hypertension:A practical guideline[J]. Histopathology, 2003, 42 (1) :2-13.

[5] VERHEIJ J, SCHOUTEN JN, KOMUTA M, et al. Histological features in western patients with idiopathic non-cirrhotic portal hypertension[J].Histopathology, 2013, 62 (7) :1083-1091.

[6] LIU X, WANG TL, XIANG CH, et al. Liver pathology in idiopathic portal hypertension[J]. Chin J Hepatol, 2007, 15 (5) :374-377. (in Chinese) 刘霞, 王泰龄, 项灿宏, 等.特发性门静脉高压的肝脏病理学分析[J].中华肝脏病杂志, 2007, 15 (5) :374-377.

[7] GUIDO M, ALVES VAF, BALABAUD C, et al. Histology of portal vascular changes associated with idiopathic non-cirrhotic portal hypertension:Nomenclature and definition[J]. Histopathology, 2018.[Epub ahead of print]

[8] WANG BE, ZHANG DF. Modern hepatology[M]. Beijing:Science Press, 2003:766-774. (in Chinese) 王宝恩, 张定凤.现代肝脏病学[M].北京:科学出版社, 2003:766-774.

[9] GUIDO M, SARCOGNATO S, SACCHI D, et al. Pathology of idiopathic non-cirrhotic portal hypertension[J]. Virchows Arch, 2018, 473 (1) :23-31.

[10] SAXENA R. Practical hepatic pathology:A diagnostic approach[M].Philadelphia:Saunders, 2011:443-454.

[9] RUSH N, SUN H, NAKANISHI Y, et al. Hepatic arterial buffer response:pathologic evidence in non-cirrhotic human liver with extrahepatic portal vein thrombosis[J]. Mod Pathol, 2016, 29 (5) :489-499.

[10] KNOCKAERT DC, ROBAEYS GK, COX EJ, et al. Suppurative pylethrombosis:A changing clinical picture[J]. Gastroenterology, 1989, 97 (4) :1028-1030.

[11] SARIN SK, KAPOOR D. Non-cirrhotic portal fibrosis:Current concepts and management[J]. J Gastroenterol Hepatol, 2002, 17 (5) :526-534.

[12] LISOVSKY M, KONSTAS AA, MISDRAJI J. Congenital extrahepatic portosystemic shunts (Abernethy malformation) :A histopathologic evaluation[J]. Am J Surg Pathol, 2011, 35 (9) :1381-1390.

[13] HAO Y, HONG X, ZHAO X. Congenital absence of the portal vein associated with focal nodular hyperplasia of the liver and congenital heart disease (Abernethy malformation) :A case report and literature review[J]. Oncol Lett, 2015, 9 (2) :695-700.

[14] HU GH, SHEN LG, YANG J, et al. Insight into congenital absence of the portal vein:is it rare?[J]. World J Gastroenterol, 2008, 14 (39) :5969-5979.

[15] TSOKOS M, ERBERSDOBLER A. Pathology of peliosis[J]. Forensic Sci Int, 2005, 149 (1) :25-33.

[16] IWATA T, ADACHI K, TAKAHASHI M. Peliosis hepatis mimicking malignant hypervascular tumors[J]. J Gastrointest Surg, 2017, 21 (6) :1095-1098.

[17] ZAK FG. Peliosis hepatis[J]. Am J Pathol, 1950, 26 (1) :1-15.

[18] KHALID SK, GARCIA-TSAO G. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia[J]. Semin Liver Dis, 2008, 28 (3) :247-258.

[19] LECLER A, RONOT M, DURAND F, et al. Massive biliary necrosis as a complication of a hereditary hemorrhagic telangiectasia[J]. Eur J Gastroenterol Hepatol, 2015, 27 (4) :471-474.

[20] TANAKA M, WANLESS IR. Pathology of the liver in BuddChiari syndrome:Portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules[J]. Hepatology, 1998, 27 (2) :488-496.

[21] CAZALS-HATEM D, VILGRAIN V, GENIN P, et al. Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome:A study in 17 explanted livers[J]. Hepatology, 2003, 37 (3) :510-519.

[22] Cooperative Group for Hepatic and Gall Diseases, Chinese Society of Gastroenterology, Chinese Medical Association. Expert consensus on diagnosis and treatment of quinazoline alkaloids-related sinusoidal obstruction syndrome (2017, Nanjing) [J]. J Clin Hepatol, 2017, 33 (9) :1627-1637. (in Chinese) 中华医学会消化病学分会肝胆疾病协作组.吡咯生物碱相关肝窦阻塞综合征诊断和治疗专家共识意见 (2017年, 南京) [J].临床肝胆病杂志, 2017, 33 (9) :1627-1637.

[23] RUBBIA-BRANDT L. Sinusoidal obstruction syndrome[J]. Clin Liver Dis, 2010, 14 (4) :651-668.

[24] KUMAR S, DELEVE LD, KAMATH PS, et al. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation[J]. Mayo Clin Proc, 2003, 78 (5) :589-598.

[25] CELLI R, ZHANG X. Pathology of alcoholic liver disease[J]. J Clin Transl Hepatol, 2014, 2 (2) :103-109.

施引文献

资源附件(0)

访问统计